SMA, rare disease treatment add to Kerala health model success story

Yet another Kerala model is now being scripted in healthcare in the treatment of rare diseases, including spinal muscular atrophy (SMA).

- SHINE JACOB

While the rest of the states are still limiting themselves around Centres of Excellence (CoEs) as part of the central scheme for SMAs, Kerala is setting a national benchmark through offering free life-saving drug therapies, multidisciplinary care, including genetics, physiotherapy, and respiratory support, and psychological support for affected families through a hub-and-spoke model.

SMA is a rare, inherited genetic disease that affects the motor neurons in the spinal cord, causing progressive muscle weakness and wasting.

The state is taking a giant leap in its efforts, taking it to global standards by roping in all medical colleges, district hospitals, and even the private sector in some areas as part of the ecosystem. It is also planning to increase the age of beneficiaries from 12 to 18 years. Gene therapy support is also under consideration, as it was approved recently.